BCNewswire Staff

30 POSTS
0 COMMENTS

Continued Trial of Trilaciclib Shows Promise in Extending Survival for Triple-Negative Breast Cancer

The next phase of an important trial for metastatic triple-negative breast cancer patients is evaluating the effectiveness of trilaciclib combined with chemotherapy. This effort, officially...

AMA Introduces New CPT Code for Seno Medical’s Breast Imaging Technology

The American Medical Association (AMA) has recently introduced a new Current Procedural Terminology (CPT) code, specifically for the Imagio Breast Imaging System developed by...

Decade-Long Triumph: Paclitaxel and Trastuzumab in Small HER2-Positive Breast Cancer

Over a notable duration of nearly 11 years, a study just published in The Lancet, confirms that the combination therapy of adjuvant paclitaxel and...

Breast Cancer Survivors Have Unique Metabolic Needs: Implications for Nutrition

A recent study from the University of Antwerp in Belgium has revealed that breast cancer survivors have higher metabolic rates relative to muscle mass...

BCI Test Predicts Breast Cancer Recurrence Risk in Hormone Therapy Patients

The Breast Cancer Index (BCI) has been validated as a tool for predicting the risk of breast cancer recurrence in postmenopausal women treated with...

BCNewswire Staff

30 POSTS
0 COMMENTS
spot_img